RhumbLine Advisers
RLYB icon

RhumbLine Advisers’s Rallybio RLYB Stock Holding History

RhumbLine Advisers’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,297
Closed -$13.9K – 4311
2024
Q2 		$13.9K Sell
1,297
-3,697
-74% -$50.1K ﹤0.01% 3932
2024
Q1 		$73.9K Buy
4,994
+149
+3% +$2.08K ﹤0.01% 3531
2023
Q4 		$92.6K Sell
4,845
-1
-0% -$24 ﹤0.01% 3475
2023
Q3 		$131K Buy
4,846
+73
+2% +$3.16K ﹤0.01% 3368
2023
Q2 		$216K Buy
4,773
+1,885
+65% +$92.4K ﹤0.01% 3207
2023
Q1 		$132K Buy
2,888
+142
+5% +$7.34K ﹤0.01% 2823
2022
Q4 		$144K Buy
2,746
+182
+7% +$10.7K ﹤0.01% 2854
2022
Q3 		$297K Buy
2,564
+165
+7% +$14.7K ﹤0.01% 2726
2022
Q2 		$145K Buy
2,399
+775
+48% +$58.2K ﹤0.01% 2996
2022
Q1 		$91K Buy
+1,624
New +$134K ﹤0.01% 2902

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CPX
Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RhumbLine Advisers's RLYB Position: Q3 2024 in Review

RhumbLine Advisers sold out of Rallybio (RLYB) in Q3 2024, closing a stake of 1,297 shares — an estimated $13.9K sold.

RhumbLine Advisers first reported a position in RLYB in Q1 2022 and held it in 10 quarters. The position peaked at $297K in Q3 2022. 49 funds tracked by Wall St. Rank hold RLYB as of Q3 2024.

  • RhumbLine Advisers reported no remaining Rallybio position as of Q3 2024 after selling out during the quarter.
  • RhumbLine Advisers sold 1,297 Rallybio shares in Q3 2024, an estimated $13.9K.
  • RhumbLine Advisers first reported a position in Rallybio in Q1 2022 and held it in 10 quarters.
  • RhumbLine Advisers's Rallybio position peaked at $297K in Q3 2022.
  • 49 funds tracked by Wall St. Rank held Rallybio as of Q3 2024.

Based on RhumbLine Advisers's 13F filing for Q3 2024, filed 12 Nov 2024.